nodes	percent_of_prediction	percent_of_DWPC	metapath
Minaprine—HTR2A—urine—polycystic ovary syndrome	0.00919	0.0925	CbGeAlD
Minaprine—CYP2D6—urine—polycystic ovary syndrome	0.00838	0.0842	CbGeAlD
Minaprine—ACHE—adrenal gland—polycystic ovary syndrome	0.00492	0.0495	CbGeAlD
Minaprine—HTR2B—adrenal cortex—polycystic ovary syndrome	0.00456	0.0459	CbGeAlD
Minaprine—MAOA—embryo—polycystic ovary syndrome	0.00456	0.0458	CbGeAlD
Minaprine—HTR2B—endometrium—polycystic ovary syndrome	0.00407	0.041	CbGeAlD
Minaprine—HTR2B—uterus—polycystic ovary syndrome	0.00375	0.0377	CbGeAlD
Minaprine—MAOA—adrenal cortex—polycystic ovary syndrome	0.00373	0.0375	CbGeAlD
Minaprine—HTR2B—adipose tissue—polycystic ovary syndrome	0.00367	0.0369	CbGeAlD
Minaprine—MAOA—endometrium—polycystic ovary syndrome	0.00333	0.0335	CbGeAlD
Minaprine—HTR2B—adrenal gland—polycystic ovary syndrome	0.00329	0.0331	CbGeAlD
Minaprine—MAOA—uterus—polycystic ovary syndrome	0.00307	0.0309	CbGeAlD
Minaprine—HTR2B—vagina—polycystic ovary syndrome	0.00305	0.0307	CbGeAlD
Minaprine—MAOA—pituitary gland—polycystic ovary syndrome	0.00302	0.0303	CbGeAlD
Minaprine—MAOA—adipose tissue—polycystic ovary syndrome	0.003	0.0302	CbGeAlD
Minaprine—DRD2—pituitary gland—polycystic ovary syndrome	0.00298	0.03	CbGeAlD
Minaprine—HTR2A—embryo—polycystic ovary syndrome	0.00297	0.0299	CbGeAlD
Minaprine—SLC6A4—endocrine gland—polycystic ovary syndrome	0.00288	0.029	CbGeAlD
Minaprine—CHRM1—endocrine gland—polycystic ovary syndrome	0.00287	0.0289	CbGeAlD
Minaprine—MAOA—adrenal gland—polycystic ovary syndrome	0.0027	0.0271	CbGeAlD
Minaprine—MAOA—female gonad—polycystic ovary syndrome	0.00251	0.0253	CbGeAlD
Minaprine—MAOA—vagina—polycystic ovary syndrome	0.0025	0.0251	CbGeAlD
Minaprine—MAOA—endocrine gland—polycystic ovary syndrome	0.00234	0.0235	CbGeAlD
Minaprine—DRD2—endocrine gland—polycystic ovary syndrome	0.00231	0.0232	CbGeAlD
Minaprine—HTR2A—pituitary gland—polycystic ovary syndrome	0.00197	0.0198	CbGeAlD
Minaprine—HTR2A—adrenal gland—polycystic ovary syndrome	0.00176	0.0177	CbGeAlD
Minaprine—HTR2A—vagina—polycystic ovary syndrome	0.00163	0.0164	CbGeAlD
Minaprine—HTR2A—endocrine gland—polycystic ovary syndrome	0.00152	0.0153	CbGeAlD
Minaprine—CYP2D6—female gonad—polycystic ovary syndrome	0.00149	0.015	CbGeAlD
Minaprine—CYP2D6—endocrine gland—polycystic ovary syndrome	0.00139	0.014	CbGeAlD
Minaprine—DRD2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000139	0.000154	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000138	0.000153	CbGpPWpGaD
Minaprine—MAOA—Metabolism—SLC2A4—polycystic ovary syndrome	0.000138	0.000153	CbGpPWpGaD
Minaprine—ACHE—Metabolism—CYP19A1—polycystic ovary syndrome	0.000137	0.000152	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000137	0.000152	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000137	0.000152	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000136	0.000151	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000135	0.00015	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000135	0.000149	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000134	0.000149	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000134	0.000149	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000134	0.000148	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000133	0.000148	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000132	0.000147	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000132	0.000147	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000132	0.000146	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000132	0.000146	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000132	0.000146	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000132	0.000146	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000131	0.000146	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—SCT—polycystic ovary syndrome	0.000131	0.000146	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000131	0.000145	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—SCT—polycystic ovary syndrome	0.00013	0.000145	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.00013	0.000145	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000129	0.000144	CbGpPWpGaD
Minaprine—MAOA—Metabolism—CYP19A1—polycystic ovary syndrome	0.000129	0.000144	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000129	0.000143	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000129	0.000143	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.000128	0.000142	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000127	0.000141	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000127	0.000141	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000127	0.000141	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000126	0.00014	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000125	0.000139	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000125	0.000139	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000124	0.000138	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000124	0.000138	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000124	0.000138	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000124	0.000138	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—INSR—polycystic ovary syndrome	0.000124	0.000137	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000123	0.000136	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000123	0.000136	CbGpPWpGaD
Minaprine—ACHE—Metabolism—GNAS—polycystic ovary syndrome	0.000123	0.000136	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000122	0.000136	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000122	0.000136	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000122	0.000135	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000122	0.000135	CbGpPWpGaD
Minaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000121	0.000135	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000121	0.000135	CbGpPWpGaD
Minaprine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000121	0.000134	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00012	0.000133	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00012	0.000133	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000119	0.000133	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000119	0.000132	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000117	0.00013	CbGpPWpGaD
Minaprine—ACHE—Metabolism—NCOR1—polycystic ovary syndrome	0.000117	0.00013	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000116	0.000129	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000116	0.000128	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000116	0.000128	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000116	0.000128	CbGpPWpGaD
Minaprine—MAOA—Metabolism—GNAS—polycystic ovary syndrome	0.000115	0.000128	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000115	0.000128	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000115	0.000128	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PRL—polycystic ovary syndrome	0.000115	0.000128	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PGR—polycystic ovary syndrome	0.000114	0.000127	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000114	0.000127	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.000114	0.000127	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000114	0.000126	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000113	0.000126	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000112	0.000125	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000112	0.000124	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000111	0.000123	CbGpPWpGaD
Minaprine—ACHE—Metabolism—CYP1A1—polycystic ovary syndrome	0.000111	0.000123	CbGpPWpGaD
Minaprine—MAOA—Metabolism—NCOR1—polycystic ovary syndrome	0.00011	0.000122	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000109	0.000122	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000109	0.000121	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000109	0.000121	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000109	0.000121	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000109	0.000121	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000108	0.00012	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—INSR—polycystic ovary syndrome	0.000107	0.000119	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000107	0.000119	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000106	0.000118	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000106	0.000118	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000105	0.000116	CbGpPWpGaD
Minaprine—MAOA—Metabolism—CYP1A1—polycystic ovary syndrome	0.000104	0.000116	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000104	0.000115	CbGpPWpGaD
Minaprine—ACHE—Metabolism—MTHFR—polycystic ovary syndrome	0.000103	0.000115	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000103	0.000114	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000102	0.000114	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000102	0.000113	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000102	0.000113	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000101	0.000113	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000101	0.000113	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000101	0.000112	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000101	0.000112	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.0001	0.000111	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	9.98e-05	0.000111	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PGR—polycystic ovary syndrome	9.93e-05	0.00011	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	9.92e-05	0.00011	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TCF7L2—polycystic ovary syndrome	9.89e-05	0.00011	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PGR—polycystic ovary syndrome	9.88e-05	0.00011	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—AKT2—polycystic ovary syndrome	9.85e-05	0.000109	CbGpPWpGaD
Minaprine—MAOA—Metabolism—MTHFR—polycystic ovary syndrome	9.72e-05	0.000108	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	9.69e-05	0.000108	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.64e-05	0.000107	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—GNAS—polycystic ovary syndrome	9.54e-05	0.000106	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—NRG1—polycystic ovary syndrome	9.46e-05	0.000105	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	9.39e-05	0.000104	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PLAT—polycystic ovary syndrome	9.39e-05	0.000104	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—GHRL—polycystic ovary syndrome	9.39e-05	0.000104	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—NGFR—polycystic ovary syndrome	9.36e-05	0.000104	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—POMC—polycystic ovary syndrome	9.3e-05	0.000103	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PRL—polycystic ovary syndrome	9.28e-05	0.000103	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PLAT—polycystic ovary syndrome	9.24e-05	0.000103	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—GHRL—polycystic ovary syndrome	9.24e-05	0.000103	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	9.19e-05	0.000102	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	9.19e-05	0.000102	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.09e-05	0.000101	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—POMC—polycystic ovary syndrome	9.04e-05	0.0001	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—ATF1—polycystic ovary syndrome	8.95e-05	9.94e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—AKT2—polycystic ovary syndrome	8.94e-05	9.93e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—NRG1—polycystic ovary syndrome	8.92e-05	9.91e-05	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	8.9e-05	9.88e-05	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	8.85e-05	9.83e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—ATF1—polycystic ovary syndrome	8.81e-05	9.78e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—ADRB2—polycystic ovary syndrome	8.8e-05	9.78e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	8.76e-05	9.73e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	8.73e-05	9.7e-05	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	8.69e-05	9.65e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	8.64e-05	9.59e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	8.59e-05	9.54e-05	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	8.55e-05	9.5e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	8.55e-05	9.49e-05	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	8.51e-05	9.45e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	8.37e-05	9.29e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—PPARG—polycystic ovary syndrome	8.37e-05	9.29e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—NGFR—polycystic ovary syndrome	8.26e-05	9.18e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—POMC—polycystic ovary syndrome	8.25e-05	9.16e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—POMC—polycystic ovary syndrome	8.21e-05	9.12e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—INS—polycystic ovary syndrome	8.2e-05	9.11e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PRL—polycystic ovary syndrome	8.19e-05	9.09e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—GNAS—polycystic ovary syndrome	8.16e-05	9.06e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—NGFR—polycystic ovary syndrome	8.13e-05	9.03e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—IRS2—polycystic ovary syndrome	8.1e-05	9e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	8.09e-05	8.98e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—POMC—polycystic ovary syndrome	8.08e-05	8.97e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	8.07e-05	8.96e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PRL—polycystic ovary syndrome	8.06e-05	8.95e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	8.04e-05	8.92e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PRL—polycystic ovary syndrome	8.02e-05	8.9e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—LEP—polycystic ovary syndrome	7.93e-05	8.81e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—AKT2—polycystic ovary syndrome	7.89e-05	8.76e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—PPARG—polycystic ovary syndrome	7.88e-05	8.75e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.78e-05	8.64e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—POMC—polycystic ovary syndrome	7.77e-05	8.63e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—ADRB2—polycystic ovary syndrome	7.77e-05	8.63e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	7.77e-05	8.62e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	7.75e-05	8.61e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—INS—polycystic ovary syndrome	7.73e-05	8.58e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	7.72e-05	8.58e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	7.65e-05	8.5e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	7.65e-05	8.49e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—IRS2—polycystic ovary syndrome	7.64e-05	8.49e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—NRG1—polycystic ovary syndrome	7.63e-05	8.48e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	7.6e-05	8.44e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—LEP—polycystic ovary syndrome	7.48e-05	8.31e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	7.23e-05	8.03e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—GNAS—polycystic ovary syndrome	7.2e-05	8e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	7.12e-05	7.9e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—GNAS—polycystic ovary syndrome	7.09e-05	7.87e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—IRS1—polycystic ovary syndrome	7.08e-05	7.86e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	7.05e-05	7.83e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—NCOR1—polycystic ovary syndrome	6.86e-05	7.62e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—POMC—polycystic ovary syndrome	6.81e-05	7.57e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—INS—polycystic ovary syndrome	6.78e-05	7.52e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	6.75e-05	7.5e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—NRG1—polycystic ovary syndrome	6.74e-05	7.48e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	6.72e-05	7.46e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—IRS1—polycystic ovary syndrome	6.67e-05	7.41e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—NRG1—polycystic ovary syndrome	6.63e-05	7.36e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	6.59e-05	7.32e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—IGF1—polycystic ovary syndrome	6.55e-05	7.28e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—AKT2—polycystic ovary syndrome	6.55e-05	7.27e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IRS2—polycystic ovary syndrome	6.54e-05	7.26e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—POMC—polycystic ovary syndrome	6.43e-05	7.13e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—LEP—polycystic ovary syndrome	6.4e-05	7.1e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—INS—polycystic ovary syndrome	6.39e-05	7.09e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.22e-05	6.91e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—IGF1—polycystic ovary syndrome	6.18e-05	6.86e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—AKT2—polycystic ovary syndrome	6.18e-05	6.86e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	6.16e-05	6.84e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	5.99e-05	6.65e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.87e-05	6.52e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IRS2—polycystic ovary syndrome	5.77e-05	6.41e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IRS1—polycystic ovary syndrome	5.71e-05	6.34e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IRS2—polycystic ovary syndrome	5.68e-05	6.3e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	5.65e-05	6.27e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—LEP—polycystic ovary syndrome	5.65e-05	6.27e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	5.63e-05	6.25e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—LEP—polycystic ovary syndrome	5.56e-05	6.17e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	5.53e-05	6.14e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—POMC—polycystic ovary syndrome	5.5e-05	6.1e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—INS—polycystic ovary syndrome	5.47e-05	6.07e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IGF1—polycystic ovary syndrome	5.29e-05	5.87e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—AKT2—polycystic ovary syndrome	5.28e-05	5.87e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IRS1—polycystic ovary syndrome	5.04e-05	5.59e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	5.03e-05	5.58e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.02e-05	5.58e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—IL6—polycystic ovary syndrome	5.01e-05	5.57e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IRS1—polycystic ovary syndrome	4.96e-05	5.5e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	4.93e-05	5.47e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—POMC—polycystic ovary syndrome	4.85e-05	5.39e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—INS—polycystic ovary syndrome	4.82e-05	5.36e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	4.79e-05	5.32e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—POMC—polycystic ovary syndrome	4.77e-05	5.3e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	4.75e-05	5.27e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—INS—polycystic ovary syndrome	4.75e-05	5.27e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—IL6—polycystic ovary syndrome	4.73e-05	5.25e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	4.72e-05	5.24e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IGF1—polycystic ovary syndrome	4.67e-05	5.18e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—AKT2—polycystic ovary syndrome	4.66e-05	5.18e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IGF1—polycystic ovary syndrome	4.59e-05	5.1e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—AKT2—polycystic ovary syndrome	4.59e-05	5.09e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	4.57e-05	5.07e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	4.56e-05	5.07e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	4.54e-05	5.04e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.43e-05	4.92e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.36e-05	4.84e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.34e-05	4.82e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.28e-05	4.75e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	4.23e-05	4.7e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—IL6—polycystic ovary syndrome	4.04e-05	4.49e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.04e-05	4.48e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—IL6—polycystic ovary syndrome	3.57e-05	3.96e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—IL6—polycystic ovary syndrome	3.51e-05	3.9e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	3.49e-05	3.88e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.45e-05	3.83e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	3.43e-05	3.81e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	3.38e-05	3.76e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	3.37e-05	3.74e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.05e-05	3.38e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	3e-05	3.33e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.98e-05	3.31e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—IL6—polycystic ovary syndrome	2.96e-05	3.29e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—IL6—polycystic ovary syndrome	2.79e-05	3.1e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IL6—polycystic ovary syndrome	2.39e-05	2.65e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IL6—polycystic ovary syndrome	2.11e-05	2.34e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IL6—polycystic ovary syndrome	2.07e-05	2.3e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	2.06e-05	2.29e-05	CbGpPWpGaD
